Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Bloss

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Current Oncology Reports|December 21, 2000
Chemotherapy for advanced or recurrent carcinoma of the cervixJ D Bloss
American Journal of Obstetrics and Gynecology|November 1, 1993
The use of electrosurgical techniques in the management of premalignant diseases of the vulva, vagina, and cervix: an excisional rather than an ablative approachJ D Bloss
Clinical Obstetrics and Gynecology|November 1, 2001
Breast cancer preventionK J Rodabaugh, J D Bloss
Gynecologic Oncology|November 1, 1995
A retrospective study of tamoxifen and endometrial cancer in breast cancer patientsD C Robinson, J D Bloss, M A Schiano
The Journal of Reproductive Medicine|June 1, 1987
Pulmonary edema as a delayed complication of ritodrine therapy. A case reportJ D Bloss, G D Hankins, L C Gilstrap, et al.
American Journal of Obstetrics and Gynecology|July 1, 1987
The effect of oxytocin infusion on the pharmacokinetics of intramuscular magnesium sulfate therapyJ D Bloss, G D Hankins, J C Hauth, et al.
Gynecologic Oncology|January 1, 1991
Use of vaginal hysterectomy for the management of stage I endometrial cancer in the medically compromised patientJ D Bloss, M L Berman, L P Bloss, et al.
American Journal of Obstetrics and Gynecology|August 1, 1991
CA 125 regression: a model for epithelial ovarian cancer responseR E Buller, M L Berman, J D Bloss, et al.
Gynecologic Oncology|January 1, 1991
Does intraperitoneal CA-125 reflect disease status?R E Buller, A Manetta, J D Bloss, et al.
Gynecologic Oncology|October 1, 1992
Serum CA125 regression in epithelial ovarian cancer: correlation with reassessment findings and survivalR E Buller, M L Berman, J D Bloss, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Oncology Reports|December 21, 2000
Chemotherapy for advanced or recurrent carcinoma of the cervixJ D Bloss
American Journal of Obstetrics and Gynecology|November 1, 1993
The use of electrosurgical techniques in the management of premalignant diseases of the vulva, vagina, and cervix: an excisional rather than an ablative approachJ D Bloss
Clinical Obstetrics and Gynecology|November 1, 2001
Breast cancer preventionK J Rodabaugh, J D Bloss
Gynecologic Oncology|November 1, 1995
A retrospective study of tamoxifen and endometrial cancer in breast cancer patientsD C Robinson, J D Bloss, M A Schiano
The Journal of Reproductive Medicine|June 1, 1987
Pulmonary edema as a delayed complication of ritodrine therapy. A case reportJ D Bloss, G D Hankins, L C Gilstrap, et al.
American Journal of Obstetrics and Gynecology|July 1, 1987
The effect of oxytocin infusion on the pharmacokinetics of intramuscular magnesium sulfate therapyJ D Bloss, G D Hankins, J C Hauth, et al.
Gynecologic Oncology|January 1, 1991
Use of vaginal hysterectomy for the management of stage I endometrial cancer in the medically compromised patientJ D Bloss, M L Berman, L P Bloss, et al.
American Journal of Obstetrics and Gynecology|August 1, 1991
CA 125 regression: a model for epithelial ovarian cancer responseR E Buller, M L Berman, J D Bloss, et al.
Gynecologic Oncology|January 1, 1991
Does intraperitoneal CA-125 reflect disease status?R E Buller, A Manetta, J D Bloss, et al.
Gynecologic Oncology|October 1, 1992
Serum CA125 regression in epithelial ovarian cancer: correlation with reassessment findings and survivalR E Buller, M L Berman, J D Bloss, et al.
Pageof 3